193 related articles for article (PubMed ID: 21083841)
1. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
Keita M; AinMelk Y; Pelmus M; Bessette P; Aris A
J Obstet Gynaecol Res; 2011 Feb; 37(2):99-107. PubMed ID: 21083841
[TBL] [Abstract][Full Text] [Related]
2. Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis.
Akoum A; Lawson C; Herrmann-Lavoie C; Maheux R
Hum Reprod; 2007 May; 22(5):1464-73. PubMed ID: 17324958
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
4. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
5. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.
Keita M; Bessette P; Pelmus M; Ainmelk Y; Aris A
J Ovarian Res; 2010 Jan; 3():3. PubMed ID: 20181040
[TBL] [Abstract][Full Text] [Related]
7. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
Nabli H; Tuller E; Sharpe-Timms KL
Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
[TBL] [Abstract][Full Text] [Related]
8. [Construction of the recombinant adenovirus vector of interleukin-1 receptor II and its expression in eutopic stromal cells of endometriosis].
Hou Z; Zhou J; Gao LY; Hu YQ; Liu JY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1102-5. PubMed ID: 18062876
[TBL] [Abstract][Full Text] [Related]
9. Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis.
Torres PB; Florio P; Ferreira MC; Torricelli M; Reis FM; Petraglia F
Fertil Steril; 2007 Jul; 88(1):200-5. PubMed ID: 17296189
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions.
Lawson C; Al-Akoum M; Maheux R; Akoum A
Reproduction; 2007 Jan; 133(1):265-74. PubMed ID: 17244752
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
12. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.
Tagashira Y; Taniguchi F; Harada T; Ikeda A; Watanabe A; Terakawa N
Fertil Steril; 2009 May; 91(5 Suppl):2185-92. PubMed ID: 18684450
[TBL] [Abstract][Full Text] [Related]
15. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
Bellehumeur C; Collette T; Maheux R; Mailloux J; Villeneuve M; Akoum A
Hum Reprod; 2005 May; 20(5):1177-84. PubMed ID: 15705625
[TBL] [Abstract][Full Text] [Related]
17. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-1 receptor type II in the pathogenesis of endometriosis.
Hou Z; Zhou J; Ma X; Fan L; Liao L; Liu J
Fertil Steril; 2008 Jan; 89(1):42-51. PubMed ID: 17482186
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis.
Herrmann Lavoie C; Fraser D; Therriault MJ; Akoum A
Am J Reprod Immunol; 2007 Dec; 58(6):505-13. PubMed ID: 17997749
[TBL] [Abstract][Full Text] [Related]
20. Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology.
Guay S; Akoum A
Reproduction; 2007 Sep; 134(3):525-34. PubMed ID: 17709570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
